JP2016513747A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513747A5
JP2016513747A5 JP2016500727A JP2016500727A JP2016513747A5 JP 2016513747 A5 JP2016513747 A5 JP 2016513747A5 JP 2016500727 A JP2016500727 A JP 2016500727A JP 2016500727 A JP2016500727 A JP 2016500727A JP 2016513747 A5 JP2016513747 A5 JP 2016513747A5
Authority
JP
Japan
Prior art keywords
compound according
compound
agent
polysaccharide
carrier protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500727A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513747A (ja
JP6434958B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/021128 external-priority patent/WO2014158963A1/en
Publication of JP2016513747A publication Critical patent/JP2016513747A/ja
Publication of JP2016513747A5 publication Critical patent/JP2016513747A5/ja
Application granted granted Critical
Publication of JP6434958B2 publication Critical patent/JP6434958B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500727A 2013-03-12 2014-03-06 真菌の細胞壁多糖成分を標的とする抗体 Expired - Fee Related JP6434958B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361777631P 2013-03-12 2013-03-12
US61/777,631 2013-03-12
PCT/US2014/021128 WO2014158963A1 (en) 2013-03-12 2014-03-06 Antibodies targeted to fungal cell wall polysaccharides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018135654A Division JP2018172696A (ja) 2013-03-12 2018-07-19 真菌の細胞壁多糖成分を標的とする抗体

Publications (3)

Publication Number Publication Date
JP2016513747A JP2016513747A (ja) 2016-05-16
JP2016513747A5 true JP2016513747A5 (enExample) 2017-03-23
JP6434958B2 JP6434958B2 (ja) 2018-12-05

Family

ID=51625093

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016500727A Expired - Fee Related JP6434958B2 (ja) 2013-03-12 2014-03-06 真菌の細胞壁多糖成分を標的とする抗体
JP2018135654A Pending JP2018172696A (ja) 2013-03-12 2018-07-19 真菌の細胞壁多糖成分を標的とする抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018135654A Pending JP2018172696A (ja) 2013-03-12 2018-07-19 真菌の細胞壁多糖成分を標的とする抗体

Country Status (10)

Country Link
US (6) US20160017062A1 (enExample)
EP (1) EP2968427B1 (enExample)
JP (2) JP6434958B2 (enExample)
CN (1) CN105188725B (enExample)
AU (1) AU2014241492A1 (enExample)
DK (1) DK2968427T3 (enExample)
ES (1) ES2936811T3 (enExample)
FI (1) FI2968427T3 (enExample)
PL (1) PL2968427T3 (enExample)
WO (1) WO2014158963A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014241492A1 (en) 2013-03-12 2015-09-17 Wellstat Vaccines, Llc Antibodies targeted to fungal cell wall polysaccharides
CN111679069A (zh) * 2019-12-31 2020-09-18 安徽中医药大学 一种通过耳道念珠菌细胞壁重构来评价中药单体抗真菌作用的方法
CN111707815A (zh) * 2019-12-31 2020-09-25 安徽中医药大学 一种通过白色念珠菌细胞壁重构来评价中药单体抗真菌作用的方法
CN113274489B (zh) * 2021-04-30 2023-08-29 山东省药学科学院 一种预防真菌感染的几丁质寡糖疫苗及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62138496A (ja) 1985-12-11 1987-06-22 Ihara Chem Ind Co Ltd キチンオリゴマ−の製造方法
JP2871822B2 (ja) * 1989-08-29 1999-03-17 玉造株式会社 末端に2,5―アンヒドロマンニトール基または2,5―アンヒドロマンノース基を有するキチン・キトサンオリゴマーおよびその製造方法
JP2868635B2 (ja) * 1991-02-25 1999-03-10 玉造株式会社 キチン・キトサンオリゴマーの精製方法
JP2786389B2 (ja) * 1993-05-18 1998-08-13 玉造株式会社 腫瘍免疫治療剤
US5705634A (en) 1995-03-02 1998-01-06 Perimmune Holdings, Inc. High yield preparation of dimeric to decameric chitin oligomers
US6284884B1 (en) * 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
DE60238858D1 (de) * 2001-11-15 2011-02-17 Biosyntech Canada Inc Zusammensetzung und verfahren um chitosan unter neutralen bedingungen homogen zu modifizieren oder vernetzen
GB0211118D0 (en) 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
CA2600696A1 (en) * 2005-03-14 2006-09-21 Governors Of The University Of Alberta Synthetic anti-candida albicans oligosaccharide based vaccines
WO2006134614A1 (en) 2005-06-14 2006-12-21 Genis Ehf. Compositions of partially deacetylated chitin derivatives
KR100793756B1 (ko) * 2006-08-07 2008-01-10 엘지전자 주식회사 녹화 목록 표시 방법 및 그 장치
US20080311595A1 (en) 2007-06-18 2008-12-18 Inger Mattsby-Baltzer Rapid fungal detection assay and product
GB2460283B (en) * 2008-03-13 2010-04-21 Academia Sinica Method of producing fibrillar proteins
EP2123261A1 (en) 2008-05-20 2009-11-25 Stallergenes S.A. Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance
CA2731384C (en) 2008-07-21 2015-03-10 The Brigham And Women's Hospital, Inc. Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
WO2010015022A1 (en) * 2008-08-05 2010-02-11 The University Of Queensland Antigen-presenting scaffolds
PL2331128T3 (pl) 2008-09-05 2014-06-30 Ceva Sante Animale Sa Kompozycja zawierająca chitozan do doocznego podawania szczepionki (szczepionek) ptakom
CA2739428C (en) * 2008-10-23 2018-04-03 The Lubrizol Corporation Lubricating composition containing metal carboxylate
JP5617127B2 (ja) * 2009-05-08 2014-11-05 大石 哲也 新規グアナミン化合物、その誘導体及びそれらの製造方法
JP5781542B2 (ja) * 2009-12-30 2015-09-24 ノバルティス アーゲー E.coliキャリアタンパク質に結合体化した多糖免疫原
JP2012241084A (ja) * 2011-05-18 2012-12-10 Nippon Terupen Kagaku Kk バインダー樹脂用溶剤
AU2014241492A1 (en) * 2013-03-12 2015-09-17 Wellstat Vaccines, Llc Antibodies targeted to fungal cell wall polysaccharides

Similar Documents

Publication Publication Date Title
Caseiro et al. From cancer therapy to winemaking: The molecular structure and applications of β-glucans and β-1, 3-glucanases
JP2020533438A5 (enExample)
JP2020533442A5 (enExample)
HRP20211288T1 (hr) Kapsularni polisaharidi bakterije streptococcus pneumoniae i njihovi konjugati
WO2011156774A3 (en) Multivalent glycopeptide constructs and uses thereof
JP2010539256A5 (enExample)
JP2016513747A5 (enExample)
JP2020533439A5 (enExample)
IL274500B2 (en) Glycoconjugation process
JP6381147B2 (ja) ピロリ菌リポ多糖類の外殻エピトープ
JP2013136639A5 (enExample)
JP2010132925A5 (enExample)
JP2014218516A5 (enExample)
JP2004536859A5 (enExample)
JP2012082199A5 (enExample)
JP2015509111A5 (enExample)
JP2011504535A5 (enExample)
CN105377282B (zh) 环炔衍生化的糖
JP2013544242A5 (enExample)
MX2012003726A (es) Conjugacion de polisacaridos capsulares de tipo 5 y de tipo 8 de staphylococcus aureus.
JP2017532321A5 (enExample)
WO2014009971A3 (en) Non-alcoholic vaccine compositions free from animal- origin and process for preparation thereof
US20160354297A1 (en) Cosmetic composition comprising at least one specific silane, at least one anionic and/or non-ionic polysaccharide and at least one water-soluble mineral salt
CZ305153B6 (cs) Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
Khan et al. Structure and bioactivities of fungal polysaccharides